PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists identify a new target for Alzheimer's disease

2010-09-22
(Press-News.org) (CHICAGO) – Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

Results from the study funded by the National Institutes of Health and the Alzheimer's Association will be published in the September 22 issue of the Journal of Neuroscience.

"There are multiple, neurotoxic, disease-causing pathways that converge on the neutral sphingomyelinase that can cause neuronal loss in the brain of an Alzheimer's patient," said Kalipada Pahan, PhD, neurological researcher and lead investigator at Rush. "If we can stop the activation of the neutral sphingomylinase, we may be able to stop memory loss and the progression of Alzheimer's disease."

In the brain of a patient with Alzheimer's disease, two abnormal structures called plaques and tangles are prime suspects in damaging and killing nerve cells. While neurons die, other brain cells like astroglia and microglia do not die. These cells become activated and glial cell activation plays a key role in the destruction of neurons. However, the molecular mechanisms by which activated glial cells can kill neurons have been poorly understood until now.

Beta-amyloid, which is a protein fragment deposited in the brains of patients who have Alzheimer's disease, causes the activation of glial cells. Neuritic plaques are mainly composed of aggregates of beta-amyloid. When healthy nerve cells in the brain are exposed to beta-amyloid, they exhibit a number of pathological changes that are characteristic of Alzheimer's pathology.

Researchers at Rush were able to determine that the neutral sphingomyelinase is triggered by the activated brain cells and beta-amyloid. However, when the neutral sphingomyelinase was inhibited by using a small molecule inhibitor and a chemical inhibitor, the activated brain cells and beta amyloid were unable to kill neurons.

Experts tested the two inhibitors using human brain cells in a mouse model and a cell culture model.

"Understanding how the disease process works is important in identifying effective approaches to protect the brain and stop the progression of Alzheimer's disease," said Pahan. "The results of this study are very promising and our next step is to translate these findings to the clinic."

"If we can develop and test a clinical medication that can target the neutral sphingomyelinase, we may be able to halt memory loss in Alzheimer's disease patients," said Pahan.

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimer's, symptoms first appear after age 60.Alzheimer's disease is the most common cause of dementia among older people. Alzheimer's disease affects as many as 5.3 million Americans.

INFORMATION:

Kalipada Pahan, PhD, is the Floyd Davis Professor of Neurology at Rush University Medical Center.

END



ELSE PRESS RELEASES FROM THIS DATE:

New study indicates children and parents want science assessment for 11-year-olds

2010-09-22
At a time when new transfer arrangements mean children in Northern Ireland will no longer be formally assessed in science at age 11, researchers at Queen's University have found overwhelming support for science assessment in primary schools in England and Wales. The study, which was conducted by researchers at Queen's School of Education on behalf of the Wellcome Trust, is the first study to look at the attitudes and concerns of children and parents on the way science is assessed in primary schools in England and Wales. It is hoped the findings will be used to inform ...

OHSU research suggests compound administered during some bone marrow transplants elevates risks

2010-09-22
PORTLAND, Ore - Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe. The VGTI research team, led by institute director Jay Nelson, Ph.D., studies human cytomegalovirus, a virus that may infect up to 80 percent of the American population. The exact percentage of infected citizens is unknown due to the fact that the virus causes minor ...

Targeted therapy triggers complex mechanism of resistance

2010-09-22
Washington, DC – In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling "network" makes a cancer cell resistant to a drug and selectively target them as well, say researchers at Georgetown Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center. In the September 21 issue of Science Signaling, the investigators discuss how cancer cells activate a network of pro-growth proteins that can bypass a molecule being therapeutically targeted. The researchers specifically found that many ...

The Joy of sets: For ants and trees, multiple partners are a boon

2010-09-22
GAINESVILLE, Fla. — In the complex world of ant-plant partnerships, serial monogamy can help trees maximize their evolutionary fitness, a new University of Florida study shows. Trees that sequentially partner with multi-species sets of ants produce more offspring than trees that maintain a lifelong association with any single ant — even when those sets include ant species that appear to harm the tree, said Todd Palmer, a UF biology professor. The study has broad implications because many of the world's ecosystems rely on cooperative partnerships between species, Palmer ...

Avoid swimming in interplanetary lakes

2010-09-22
Titan, one of Saturn's moons, is the only moon in the solar system with an atmosphere ― ten times denser than the atmosphere of Earth. Five years ago, the Cassini–Huygens mission to Saturn, a collaboration between the European Space Agency and NASA, sent a probe through Titan's atmosphere, revealing that Titan is home to a landscape that includes hills, valleys and most notably lakes. A researcher involved with the mission, Prof. Akiva Bar-Nun of Tel Aviv University's Department of Geophysics and Planetary Sciences, has now determined the composition of these lakes. ...

Universal, primordial magnetic fields discovered in deep space by UCLA, Caltech physicists

2010-09-22
Scientists from the California Institute of Technology and UCLA have discovered evidence of "universal ubiquitous magnetic fields" that have permeated deep space between galaxies since the time of the Big Bang. Caltech physicist Shin'ichiro Ando and Alexander Kusenko, a professor of physics and astronomy at UCLA, report the discovery in a paper to be published in an upcoming issue of Astrophysical Journal Letters; the research is currently available online. Ando and Kusenko studied images of the most powerful objects in the universe — supermassive black holes that ...

Spare the rod, spoil the child?

2010-09-22
Grabbing a child firmly by the arm, yelling and repeatedly punishing him or her may not be without long-terms risks, according to researchers from the Université de Montréal. They are studying how this harsh parenting can impair the emotional development of a child, possibly leading to anxiety disorders such as social phobia, separation anxiety and panic attacks. "Several studies have shown that coercive parenting practices are linked to anxiety," says Françoise Maheu a professor at the Université de Montréal's Department of Psychiatry and lead investigator of the study. ...

'Synthetic lethality' strategy improves molecularly targeted cancer therapy

2010-09-22
PHILADELPHIA (September 21, 2010)—Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them—but only if it was the right second agent. One well-validated molecular target for anti-cancer drugs is the epidermal growth factor receptor, or EGFR. Using a novel screening approach, ...

Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up

2010-09-22
OAK BROOK, Ill. – September 21, 2010 – Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal ...

Queen's University researchers locate impulse control center in brain

2010-09-22
Impulsive behaviour can be improved with training and the improvement is marked by specific brain changes, according to a new Queen's University study. A research team led by neuroscience PhD student Scott Hayton has pinpointed the area of the brain that controls impulsive behavior and the mechanisms that affect how impulsive behavior is learned. The findings could have a significant impact on the diagnosis and treatment of several disorders and addictions, including ADHD and alcoholism. "In the classroom, kids often blurt out answers before they raise their hand. ...

LAST 30 PRESS RELEASES:

Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement

Demographic shifts could boost drug-resistant infections across Europe

Insight into how sugars regulate the inflammatory disease process

PKU scientists uncover climate impacts and future trends of hailstorms in China

Computer model mimics human audiovisual perception

AC instead of DC: A game-changer for VR headsets and near-eye displays

Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity

Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes

Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target

A new patch could help to heal the heart

New study shows people with spinal cord injuries are more likely to develop chronic disorders

Heat as a turbo-boost for immune cells

Jülich researchers reveal: Long-lived contrails usually form in natural ice clouds

Controlling next-generation energy conversion materials with simple pressure

More than 100,000 Norwegians suffer from work-related anxiety

The American Pediatric Society selects Dr. Harolyn Belcher as the recipient of the 2026 David G. Nichols Health Equity Award

Taft Armandroff and Brian Schmidt elected to lead Giant Magellan Telescope Board of Directors

FAU Engineering receives $1.5m gift to launch the ‘Ubicquia Innovation Center for Intelligent Infrastructure’

Japanese public show major reservations to cell donation for human brain organoid research

NCCN celebrates expanding access to cancer treatment in Africa at 2025 AORTIC Meeting with new NCCN adaptations for Sub-Saharan Africa

Three health tech innovators recognized for digital solutions to transform cardiovascular care

A sequence of human rights violations precedes mass atrocities, new research shows

Genetic basis of spring-loaded spider webs

Seeing persuasion in the brain

Allen Institute announces 2025 Next Generation Leaders

Digital divide narrows but gaps remain for Australians as GenAI use surges

Advanced molecular dynamics simulations capture RNA folding with high accuracy

Chinese Neurosurgical Journal Study unveils absorbable skull device that speeds healing

Heatwave predictions months in advance with machine learning: A new study delivers improved accuracy and efficiency

2.75-million-year-old stone tools may mark a turning point in human evolution

[Press-News.org] Scientists identify a new target for Alzheimer's disease